B. Riley Wealth Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,341
| Closed | -$228K | – | 1547 |
|
|
2023
Q1 | $228K | Sell |
2,341
-281
| -11% | -$27.3K | 0.01% | 1227 |
|
|
2022
Q4 | $271K | Buy |
+2,622
| New | +$271K | 0.01% | 1092 |
|
|
2022
Q2 | – | Sell |
-3,750
| Closed | -$290K | – | 1253 |
|
|
2022
Q1 | $290K | Sell |
3,750
-34
| -0.9% | -$2.63K | 0.01% | 1031 |
|
|
2021
Q4 | $335K | Sell |
3,784
-221
| -6% | -$19.6K | 0.01% | 1014 |
|
|
2021
Q3 | $316K | Sell |
4,005
-307
| -7% | -$24.2K | 0.01% | 1013 |
|
|
2021
Q2 | $352K | Buy |
4,312
+312
| +8% | +$25.5K | 0.01% | 937 |
|
|
2021
Q1 | $312K | Buy |
4,000
+706
| +21% | +$55.1K | 0.01% | 972 |
|
|
2020
Q4 | $290K | Sell |
3,294
-112
| -3% | -$9.86K | 0.02% | 771 |
|
|
2020
Q3 | $290K | Sell |
3,406
-66
| -2% | -$5.62K | 0.02% | 722 |
|
|
2020
Q2 | $429K | Sell |
3,472
-1,955
| -36% | -$242K | 0.03% | 507 |
|
|
2020
Q1 | $460K | Buy |
+5,427
| New | +$460K | 0.04% | 413 |
|
|
2019
Q3 | – | Sell |
-3,030
| Closed | -$261K | – | 815 |
|
|
2019
Q2 | $261K | Buy |
+3,030
| New | +$261K | 0.03% | 620 |
|
|
2015
Q1 | – | Sell |
-131
| Closed | -$12 | – | 732 |
|
|
2014
Q4 | $12 | Buy |
+131
| New | +$12 | ﹤0.01% | 2765 |
|
|
2014
Q3 | – | Sell |
-320
| Closed | -$19.9K | – | 788 |
|
|
2014
Q2 | $19.9K | Buy |
+320
| New | +$19.9K | ﹤0.01% | 1475 |
|